Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca sells rare cancer drug to Sanofi for up to $300 million
AstraZeneca sells rare cancer drug to Sanofi for up to $300 million
AstraZeneca sells rare cancer drug to Sanofi for up to $300 million
Submitted by
admin
on July 27, 2015 - 10:00am
Source:
Yahoo/Reuters
News Tags:
AstraZeneca
Sanofi
Caprelsa
medullary thyroid cancer
Headline:
AstraZeneca sells rare cancer drug to Sanofi for up to $300 million
Do Not Allow Advertisers to Use My Personal information
